Atazanavir atazanavir is a structural analog of the transition state during which the bond between a phenylalanine and proline is broken. Humans do not have any enzymes that break bonds between phenylalanine and proline, so this drug will not target human enzymes. Atazanavir is available as a 150 mg capsule, 200 mg capsule, 300 mg capsule, and 50 mg oral powder packet. The 300 mg capsule should reduce pill burden, as one 300 mg capsule may replace two 150 mg capsules. Atazanavir Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.
Arguments for and against drug prohibition succession of committees and reports including, in the United Kingdom alone, the Police Foundation, the Home Affairs Select Committee, the Prime Minister's Strategy Unit, the Royal Society of Arts, and the UK Drug Policy Consortium. The United Nations Office of Drugs and Crime has also acknowledged the many "unintended negative consequences" of drug enforcement. The editor of the "British Medical Journal", Dr. Fiona Godlee, gave her personal support to Rolles' call for decriminalisation, and the arguments drew particular support from Sir Ian Gilmore, former president of the Royal College of Physicians, who said we should be treating drugs "as a